TScan Therapeutics Inc.

NASDAQ: TCRX
Share price (12/20/24): $2.97
Market cap (12/20/24): $159 million

Warning: Large portions of this site require JavaScript enabled in order to function properly. Please make sure JavaScript is enabled in your browser.

Please let us know at support@bamsec.com if you have any questions or concerns.

Search in Documents

Key Exhibits

External Links

Financials Filter

ended 09/30/24 Q3

ended 06/30/24 Q2

ended 03/31/24 Q1

ended 12/31/23 FY 2023 – amended

ended 12/31/23 FY 2023

Prospectuses and Registrations Filter

Registration of securities for employees

Prospectus supplement for primary offering

Free writing prospectus

Prospectus supplement for primary offering

Shelf registration

Ownership Filter

Nichols Weston, Lynx1 Capital Management LP

Nichols Weston, Lynx1 Capital Management LP

Cormorant Asset Management, LP

K2 HealthVentures Equity Trust LLC

Biotechnology Value Fund L P

News Filter

Refinances Existing Convertible Debt Facility With Term Loan for Up to $52.5 Million From Silicon Valley Bank

To Present Updated Data From the Ongoing ALLOHA™ Phase 1 Heme Trial During Oral Session at the 66th American Society of Hematology Annual Meeting and Exposition

Unregistered Sales of Equity Securities

Reports Third Quarter 2024 Financial Results and Provides Corporate Update

Material Definitive Agreement, Financial Statements or Exhibits

Proxies Filter

Additional info about upcoming vote

Definitive proxy

Additional info about upcoming vote

Additional info about upcoming vote

Definitive proxy

Other Filter

Scanned paper annual report submission

Notice of effectiveness

Correspondence with the SEC

Letter from the SEC

Notice of effectiveness